For example, MW151 suppressed IL-1β levels back to basal in the AD-relevant APP/PS1 KI mice whether administration was for 1 week or 5 month duration, but IBA1 staining was only suppressed with 5 month of treatment [19]. The gene discussed is APP; the disease is Alzheimer disease.